Cancer Neutron Capture Therapy

Nonfiction, Health & Well Being, Medical, Specialties, Dermatology, Oncology
Cover of the book Cancer Neutron Capture Therapy by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781475795677
Publisher: Springer US Publication: June 29, 2013
Imprint: Springer Language: English
Author:
ISBN: 9781475795677
Publisher: Springer US
Publication: June 29, 2013
Imprint: Springer
Language: English

There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994.

More books from Springer US

Cover of the book Traditional Foods by
Cover of the book Mechanisms of Cancer Metastasis by
Cover of the book Aging in European Societies by
Cover of the book Heterogeneity in Asthma by
Cover of the book Thyroid Cancer by
Cover of the book Currency Crises in Emerging Markets by
Cover of the book Investing for Sustainability by
Cover of the book Frozen Section Library: Gynecologic Pathology Intraoperative Consultation by
Cover of the book Designs for Learning Environments of the Future by
Cover of the book Web 2.0 & Semantic Web by
Cover of the book History and Climate by
Cover of the book Handbook of Clinical Health Psychology by
Cover of the book Chile 1970–73: Economic Development and Its International Setting by
Cover of the book Clinical Management of Malignant Melanoma by
Cover of the book Crystal Identification with the Polarizing Microscope by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy